Rice xanthomonas engineering bacteria as well as construction method and application thereof

By constructing the T. 2011-10-10-10-10-10-10-10-10-10-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100-100- and biosafety, suitable for a wide range of plant pest control.

CN118879601APending Publication Date: 2024-11-01SOUTHERN UNIVERSITY OF SCIENCE AND TECHNOLOGY
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410988635.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-23
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The existing plant disease control methods rely on chemical pesticides, and there are problems of environmental pollution and drug-resistant pathogens. Biocontrol technology has not been fully promoted, especially in the process of plant vegetative growth and flowering and fruiting, and the diversity of chassis strains is insufficient.

Method used

The engineering bacteria of T3SS and T6SS-2 effector protein genes were constructed to reduce pathogenicity to plants by knocking out T3SS and T6SS-2 effector protein genes, and knocking out specific genes through homologous recombination exchange method to form new Biocontrol strains are used to efficiently disinfect pathogens and maintain biosafety.

Benefits of technology

It has achieved efficient bactericidalization of a variety of pathogens, reduced the impact on plant vegetative growth and flowering fruit, provided safer and more effective biological control methods, broadened the biological control bacteria species library, and is suitable for pests and diseases of dicotyledon and monocotyledon plants. Prevention and control.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure HDA0004958235120000011
    Figure HDA0004958235120000011
  • Figure HDA0004958235120000012
    Figure HDA0004958235120000012
  • Figure HDA0004958235120000021
    Figure HDA0004958235120000021
Patent Text Reader

Abstract

The invention relates to xanthomonas oryzae engineering bacteria as well as a construction method and application thereof. Relative to wild type xanthomonas oryzae, the engineering bacterium meets one or more of the following conditions: (1) T3SS is inactivated; (2) deleting the tleA gene and the tliA gene; or / and the tleB gene and the tliB gene are deleted. The engineering bacterium can kill pathogenic bacteria and has higher biological safety.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the field of bioengineering technology, and in particular to an engineered bacterium of Xanthomonas oryzae, a construction method thereof, and an application thereof. Background Art

[0002] Agriculture plays an important role in feeding the world's population and generating income. With the continuous development of science and technology, agricultural technology has also undergone tremendous changes, but the global food production losses caused by plant diseases are still huge every year. In the current plant disease control, chemical pesticides are mainly used. Due to the toxicity of chemical pesticides, environmental unfriendliness, the occurrence of drug-resistant pathogens, the increasing ban on existing pesticides and the reduction in new pesticide registrations, it is extremely urgent to develop better agents to control plant pathogenic microorganisms, increase crop yields and ensure future food security, and also escort the development of green agriculture. Biological control is a new method of using environmentally friendly microorganisms to control pathogenic microorganisms, including phage control technology, microbiome technology, etc., but because there are still many problems to be solved in different technologies, it has not been widely promoted.

[0003] The bacterial type VI secretion system (T6SS) is a contractile protein complex widely distributed in Gram-negative bacteria that can deliver toxin proteins to neighboring bacteria or eukaryotic cells. Antimicrobial effectors are mainly toxins that inhibit the growth of other species and help reshape the ecological niche.

[0004] At present, the evaluation system for biological control using bacterial T6SS is imperfect, and the impact on plants other than nutritional growth is unknown. If a more comprehensive evaluation can be carried out, such as flowering and fruiting, ecological safety during use can be ensured. There are not many chassis strains for biological control using bacterial T6SS, and more chassis strains need to be developed to improve their diversity and reduce the tolerance of pathogens. Summary of the invention

[0005] Based on this, it is necessary to provide an engineered bacterium of Xanthomonas oryzae in one embodiment of the present application, which can disinfect pathogens while being more biosafe.

[0006] The technical solutions include the following:

[0007] An engineered strain of Xanthomonas oryzae, wherein relative to a wild-type Xanthomonas oryzae, the engineered strain satisfies one or more of the following conditions:

[0008] (1) T3SS inactivation;

[0009] (2) The tleA gene and the tliA gene are deleted; or / and, the tleB gene and the tliB gene are deleted.

[0010] In one embodiment, the T3SS in the engineered bacteria is inactivated, and the tleA gene, tliA gene, tleB gene and tliB gene are deleted.

[0011] In one embodiment, the wild-type Xanthomonas oryzae includes strain PXO99A.

[0012] In one embodiment, the hrcU gene is deleted in the engineered bacteria.

[0013] In one embodiment, the construction method comprises the following steps: using wild-type Xanthomonas oryzae as a starting bacterium, and obtaining the starting bacterium by one or more of the following methods:

[0014] (1) Inactivation of T3SS;

[0015] (2) knocking out the tleA gene and the tliA gene; or / and, knocking out the tleB gene and the tliB gene.

[0016] In one embodiment, the step of inactivating the T3SS comprises knocking out the hrcU gene.

[0017] In one embodiment, the knockout method comprises homologous recombination exchange.

[0018] In one embodiment, the step of knocking out the hrcU gene comprises:

[0019] Connecting the upstream gene fragment and the downstream gene fragment of the hrcU gene to the suicide vector to obtain a recombinant suicide plasmid vector;

[0020] The recombinant suicide plasmid vector is introduced into the starting bacteria to screen the hrcU gene knockout strain.

[0021] In one embodiment, knocking out the tleA gene, the tliA gene, the tleB gene and the tliB gene comprises the following steps:

[0022] The upstream gene fragment of the tliA gene and the downstream gene fragment of the tleB gene are connected to the suicide vector to obtain a recombinant suicide plasmid vector;

[0023] The recombinant suicide plasmid vector is introduced into the starting bacteria or the hrcU gene knockout strain, and the tleA, tliA, tleB and tleB gene knockout strains are screened.

[0024] The engineering bacteria are used in the following applications:

[0025] (1) Preparation of products for the prevention and treatment of animal and plant pathogens;

[0026] (2) Preparation of pesticides for preventing and controlling plant diseases.

[0027] In one embodiment, the animal pathogenic bacteria include one or more of E. coli DAEC 2787, E. coli ETEC H-10407, Vibrio cholerae C6706 and Citrobacter rodentium.

[0028] In one embodiment, the plant pathogenic bacteria include one or more of Pseudomonas syringaepv.syringae, P.syringae pv.tomato, and Ralstonia solanacearum GMI1000.

[0029] A product comprising the engineered bacteria.

[0030] Compared with the prior art, this application has the following beneficial effects:

[0031] This application uses Xanthomonas oryzae as the starting strain, which inactivates T3SS and makes it lose its pathogenicity to plants; in order to make it more biosafe, this application also knocks out the T6SS-2 effector protein and immune protein genes tliA, tleA, tliB, and tleB in Xanthomonas oryzae, so that it loses its effect on plant vegetative growth while also eliminating the effect on plant flowering and fruiting. The engineered strain constructed in this application can efficiently disinfect pathogens and has high biosafety. It is a new biological control chassis strain, which broadens the biological control strain library and can also be developed for the control of diseases and pests of dicotyledons and monocotyledons, and has broad application prospects in the field of green agriculture. BRIEF DESCRIPTION OF THE DRAWINGS

[0032] Figure 1 This is the result of bioinformatics prediction of the T6SS gene cluster of the whole genome of Xanthomonas oryzae PXO99A; the number "0265" in the figure is the abbreviation of PXO_00265, old_locus_tag="PXO_00265", corresponding locus_tag="PXO_RS07325", and the same applies to other numbers in the figure.

[0033] Figure 2 is the secretion activity of Xanthomonas oryzae T6SS-2Hcp; WT is the wild-type Xanthomonas oryzae, ΔtssB1 is the T6SS-1 inactivated strain, ΔtssB2 is the T6SS-2 inactivated strain, and ΔtssB1ΔtssB2 is the T6SS-1 and T6SS-2 inactivated strains.

[0034] Figure 3The bactericidal activity of different mutant strains of Xanthomonas oryzae PXO99A against Gram-negative bacteria Escherichia coli; A is the survival of Escherichia coli MG1655, B is the survival of Xanthomonas oryzae; WT is the wild-type Xanthomonas oryzae, ΔtssB1 is the T6SS-1 inactivated strain, ΔtssB2 is the T6SS-2 inactivated strain, and ΔtssB1ΔtssB2 is the T6SS-1 and T6SS-2 inactivated strains. The biological experiment was repeated three times, and the data are expressed as mean±SD (n=3). Two-tailed Student's t-test was used for statistical analysis (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).

[0035] Figure 4 The hypersensitive reactions of different mutants of Xanthomonas oryzae on tobacco; Control is 10 mM MgCl2 solution, WT is wild-type Xanthomonas oryzae, ΔhrcU is a T3SS inactivated strain, ΔtssB1ΔtssB2 is a strain inactivated for both T6SS-1 and T6SS-2, and ΔhrcU&ΔtssB1&tssB2 is a strain inactivated for both T3SS and T6SS.

[0036] Figure 5 The figure shows the effect of different mutants of Xanthomonas oryzae infecting Arabidopsis inflorescence on ovule development. MgCl2 is 10mM MgCl2 solution, WT is wild-type Xanthomonas oryzae, T6SS-2 is T6SS-2 inactivated strain (ΔtssM2), ΔtelA is a strain lacking both tleA and tliA, ΔtleB is a strain lacking both tleB and tliB, and ΔtleA-B is a strain lacking tleA, tliA, tleB, and tliB. The significant differences were marked by the heart method, the same letters indicate no significant difference between the two, and different letters indicate significant difference between the two.

[0037] Figure 6 Bactericidal activity of different mutant strains of Xanthomonas oryzae against four animal pathogens and survival of the bacteria themselves; A is the survival of pathogens, B is the survival of Xanthomonas oryzae; WT is the wild-type Xanthomonas oryzae, ΔtssM2 is the T6SS-2 inactivated strain, ΔhrcU is the T3SS inactivated strain, and ΔhrcU / tleA-B is the T3SS inactivated strain with deletion of T6SS-2 effector protein and immune protein genes tliA, tleA, tliB, tleB. Two-tailed Student's t-test was used for statistical analysis (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001).

[0038] Figure 7The figures are the fungicidal activities of different mutant strains of Xanthomonas oryzae against three plant pathogens; A is the survival of pathogens, B is the survival of Xanthomonas oryzae; WT is the wild-type Xanthomonas oryzae, ΔtssM2 is the T6SS-2 inactivated strain, ΔhrcU is the T3SS inactivated strain, and ΔhrcU / tleA-B is the T3SS inactivated strain with deletion of effector protein and immune protein genes tliA, tleA, tliB, tleB. Two-tailed Student's t-test was used for statistical analysis (*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001). DETAILED DESCRIPTION

[0039] In order to make the above-mentioned purposes, features and advantages of the present application more obvious and easy to understand, the specific implementation methods of the present application are described in detail below. In the following description, many specific details are set forth to facilitate a full understanding of the present application. However, the present application can be implemented in many other ways different from those described herein, and those skilled in the art can make similar improvements without violating the connotation of the present application, so the present application is not limited by the specific embodiments disclosed below.

[0040] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as those commonly understood by those skilled in the art to which this application belongs. The terms used herein in the specification of this application are only for the purpose of describing specific embodiments and are not intended to limit this application.

[0041] As used herein, the term "and / or" includes any and all combinations of one or more of the associated listed items.

[0042] Xanthomonas oryzae pv.oryzae PXO99A, complete sequence can be found in GenBank: NC_010717.2 or other common databases.

[0043] This application is mainly based on the ability of T6SS to disinfect bacteria, and transforms it into a new type of green biological control agent. Using bioinformatics technology, it was analyzed that Xanthomonas oryzae encodes two large T6SS gene clusters, T6SS-1 (PXO_00273-PXO_00265) and T6SS-2 (PXO_02064-PXO_05696) ( Figure 1). In addition, there are 10 small gene clusters containing VgrG, chaperone protein DUF4123 or PAAR. According to the characteristics of the effector protein, a total of 21 potential effector protein genes were predicted. The T6SS of Xanthomonas oryzae was inactivated and some predicted effector protein genes were knocked out. Secretion experiments and bactericidal experiments confirmed that Xanthomonas oryzae has secretion activity and bactericidal activity against a variety of bacteria.

[0044] Xanthomonas oryzae pv.oryzae infects rice and causes rice bacterial leaf blight, which is one of the most destructive rice diseases in the world and can reduce yield by 10% to 30%, or 50%, or even cause a total crop failure. PXO99A has a series of virulence factors, among which T3SS plays a vital role in the pathogenicity of Xanthomonas oryzae-rice interaction. It was also found that PXO99A can inhibit ovule development when infecting Arabidopsis inflorescences. Therefore, the present application genetically modifies the pathogen to inactivate T3SS and delete T6SS effector protein and immune protein genes tleA, tliA, tleB, and tliB, retaining T6SS and its bactericidal ability to carry out biological control of plant diseases.

[0045] One embodiment of the present application provides an engineered strain of Xanthomonas oryzae. Compared with wild-type Xanthomonas oryzae, the engineered strain satisfies one or more of the following conditions:

[0046] (1) T3SS inactivation;

[0047] (2) The tleA gene and the tliA gene are deleted; or / and, the tleB gene and the tliB gene are deleted.

[0048] In a preferred specific example, the T3SS in the engineered bacteria is inactivated, and the tleA gene, tliA gene, tleB gene and tliB gene are deleted. The engineered strain has high efficiency in disinfecting pathogens, which not only loses the effect on plant vegetative growth, but also eliminates the effect on plant flowering and fruiting, and has higher biosafety.

[0049] In one specific example, the wild-type Xanthomonas oryzae includes strain PXO99A.

[0050] In one specific example, the hrcU gene is deleted in the engineered bacteria.

[0051] An embodiment of the present application provides a method for constructing the engineered bacteria, the method comprising the following steps:

[0052] The wild-type Xanthomonas oryzae is used as the starting bacterium, and the starting bacterium is obtained by one or more of the following methods:

[0053] (1) Inactivation of T3SS;

[0054] (2) knocking out the tleA gene and the tliA gene; or / and, knocking out the tleB gene and the tliB gene.

[0055] Among them, tleA and tleB are T6SS-2 effector proteins, tliA is the immune protein of tleA effector protein, and tliB is the immune protein of tleB effector protein.

[0056] In one specific example, knocking out the hrcU gene inactivates the T3SS.

[0057] In one specific example, the knockout method includes homologous recombination exchange.

[0058] The present invention uses homologous recombination technology to knock out the structural protein hrcU of T3SS, thereby making T3SS inactive and thus losing its pathogenicity to plants. In order to make it more biosafe, the present invention also knocks out the T6SS-2 effector protein and immune protein genes tliA, tleA, tliB, and tleB in PXO99A to obtain PXO99A. (T3SS / TleA-B) The strain has strong bactericidal activity against a variety of important animal pathogens and plant pathogens, can kill bacteria quickly and efficiently, and has great application potential in agricultural production and medical treatment. While losing the effect on plant nutritional growth, it also eliminates the impact on plant flowering and fruiting, and has better biosafety.

[0059] In a specific example, the method for knocking out the hrcU gene in the starting bacteria includes the following steps S1 to S2:

[0060] Step S1, connecting the upstream gene fragment and the downstream gene fragment of the hrcU gene to the suicide vector to obtain a recombinant suicide plasmid vector.

[0061] Specifically, the primers for amplifying the upstream gene fragment include those shown in SEQ ID NOs. 5-6, and the primers for amplifying the downstream gene fragment include those shown in SEQ ID NOs. 7-8.

[0062] Step S2, introducing the recombinant suicide plasmid vector into the starting bacteria to screen for hrcU gene knockout strains.

[0063] In a specific example, the suicide vector includes pK18mobsacB, and sacB is used to perform counter-selection using sucrose to screen for hrcU gene knockout strains.

[0064] In a specific example, knocking out the tleA gene, the tliA gene, the tleB gene and the tliB gene includes the following steps a to b:

[0065] Step a, connecting the upstream gene fragment of the tliA gene and the downstream gene fragment of the tleB gene to a suicide vector to obtain a recombinant suicide plasmid vector.

[0066] Specifically, the primers for amplifying the upstream gene fragment include those shown in SEQ ID NOs. 9-10, and the primers for amplifying the downstream gene fragment include those shown in SEQ ID NOs. 11-12.

[0067] Step b, introducing the recombinant suicide plasmid vector into the starting bacteria or the hrcU gene knockout strain, and screening the tleA, tliA, tleB and tliB gene knockout strains.

[0068] One embodiment of the present application also provides the use of the engineered bacteria as a product for preventing and controlling animal pathogens and plant pathogens.

[0069] In one specific example, products include, but are not limited to, biologics, bactericides, bacteriostatics, and pharmaceuticals.

[0070] In a specific example, the animal pathogenic bacteria include, but are not limited to, one or more of E. coli DAEC 2787, E. coli ETEC H-10407, Vibrio cholerae C6706, and Citrobacter rodentium.

[0071] In a specific example, the plant pathogenic bacteria include but are not limited to one or more of Pseudomonas syringaepv.syringae, P.syringae pv.tomato, and Ralstonia solanacearum GMI1000.

[0072] One embodiment of the present application also provides the use of the engineered bacteria as a drug for preventing and treating plant diseases.

[0073] In a specific example, the medicament further includes excipients, such as corn starch and the like.

[0074] In a specific example, the dosage form of the agent includes but is not limited to powder, etc. When the powder is used, it can be directly diluted with water for spraying or root irrigation on plants.

[0075] The agent containing the engineered bacteria of the present application can be applied to plants and can be used to prevent and treat plant diseases caused by Pseudomonas syringae, Ralstonia solanacearum and the like.

[0076] An embodiment of the present application also provides a bactericide, comprising the above-mentioned engineered bacteria.

[0077] One embodiment of the present application also provides a drug for preventing and treating plant diseases, wherein the active ingredient of the drug includes the above-mentioned engineered bacteria.

[0078] The culture solution containing the engineered bacteria of the present application can be directly used as a drug for preventing and treating plant diseases; the culture solution can also be dried into powder by conventional methods and used as a raw material for fungicidal active ingredients and other conventional auxiliary materials to prepare a drug for preventing and treating plant diseases.

[0079] The engineered bacteria are cultured using NB liquid culture medium to obtain a culture solution of the engineered bacteria. The NB liquid culture medium (w / v) includes 0.3% beef extract, 0.1% yeast powder, 0.5% polypeptone and 1% sucrose; the culture conditions include 28°C, 200-300 rpm, and culture for 15-20 hours.

[0080] The embodiments of the present application will be described in detail below in conjunction with examples. It should be understood that these examples are only used to illustrate the present application and are not intended to limit the scope of the present application. The experimental methods for which specific conditions are not specified in the following examples are preferably referred to the guidance provided in the present application, and can also be based on the experimental manual or normal conditions in this area, can also be based on the conditions recommended by the manufacturer, or refer to experimental methods known in the art.

[0081] In the following specific embodiments, the measured parameters of raw material components may have slight deviations within the range of weighing accuracy unless otherwise specified. For temperature and time parameters, acceptable deviations caused by instrument test accuracy or operation accuracy are allowed.

[0082] Example 1

[0083] 1. Prediction of T6SS genes in Xanthomonas oryzae genome

[0084] The NCBI database (https: / / www.ncbi.nlm.nih.gov) was used to search for T6SS structural marker genes such as vgrG, hcp and paar in the genome of Xanthomonas oryzae. Combined with upstream and downstream gene sequence analysis, a total of 2 T6SS large gene clusters and 10 small gene clusters were retrieved in Xanthomonas oryzae. Further analysis showed that there were 21 potential effector protein encoding genes (PXO_00272, PXO_02058, PXO_02056, PXO_02037, PXO_02034, PXO_02032, PXO_05538, PXO_RS00500, PXO_00498, PXO_01369, PXO_01528, PXO_02456, PXO_02459, PXO_02463, PXO_RS27400, PXO_03643, PXO_03639, PXO_RS01450, PXO_RS30235, PXO_04252, and PXO_04701) on the X. oryzae genome. Figure 1 shown.

[0085] 2. Construction of Xanthomonas oryzae engineered strains

[0086] 2.1PXO99A T6SS-2- (ΔtssM2) engineering bacteria construction

[0087] The wild-type Xanthomonas oryzae PXO99A was used as the starting strain, and the upstream and downstream fragments of the gene tssM2 were amplified by about 1 kb each. The upstream and downstream fragments were connected to the vector pK18mobSacB using the Gibson recombination technology. After accurate sequencing, they were introduced into the PXO99A wild-type bacteria by conjugation transfer. Then, SacB was used for counter-selection using sucrose to obtain the tssM2 gene deletion strain, that is, the T6SS-2 inactivated engineered strain PXO99A constructed by the present invention. T6SS-2- (ΔtssM2).

[0088] Primers for amplifying the upstream fragment of gene tssM2:

[0089] F: GATTACGAATTCGAGCTCGGaaggcccgttggagcatcac (SEQ ID NO. 1);

[0090] R:ttggccaccttcttggagaattgctgaacatcgggtgct (SEQ ID NO. 2).

[0091] Primers for amplifying the downstream fragment of gene tssM2:

[0092] F: atgttcagcaatctccaagaaggtggccaatgagtc (SEQ ID NO.3);

[0093] R: AGTCACGACGTTGTAAAACGAcatattcatgtccccaggaaagt (SEQ ID NO. 4).

[0094] 2.2PXO99A T3SS- (ΔhrcU) engineering bacteria construction

[0095] The wild-type Xanthomonas oryzae PXO99A was used as the starting strain, and the upstream and downstream fragments of the gene hrcU were amplified by about 1 kb each. The upstream and downstream fragments were connected to the vector pK18mobSacB using the Gibson recombination technology. After accurate sequencing, they were introduced into the PXO99A wild-type bacteria by conjugation transfer. Subsequently, SacB was used for counter-selection using sucrose to obtain the hrcU gene-deficient strain, that is, the T3SS-inactivated engineered strain PXO99A constructed by the present invention. T3SS- (ΔhrcU).

[0096] Primers for amplifying the upstream fragment of the hrcU gene:

[0097] F: GATTACGAATTCGAGCTCGG CAACTTGCGCTGATCGTTG(SEQ ID NO.5);

[0098] R:GGAAGAAAAAGCCCTGCCATGCTAGGAG (SEQ ID NO. 6).

[0099] Primers for amplifying the downstream fragment of the hrcU gene:

[0100] F: ATGGCAGGGCTTTTTCTTCCGACATTGCCTTAT (SEQ ID NO. 7);

[0101] R: AGTCACGACGTTGTAAAACGA AGCTCGTGCATCAACTTGATCT (SEQ ID NO. 8).

[0102] 2.3PXO99A (T3SS / TleA-B) (ΔhrcU / tleA-B) engineering bacteria construction

[0103] PXO99A T3SS-(ΔhrcU) was the starting strain. The upstream fragment of the gene tliA was amplified by about 500 bp, and the downstream fragment of the gene tleB was amplified by about 500 bp. The upstream and downstream fragments were connected to the vector pK18mobSacB using Gibson recombination technology. After accurate sequencing, they were introduced into PXO99A by conjugation transfer. T3SS -(ΔhrcU) bacteria, and then counter-selected with sucrose using SacB to obtain a strain with T6SS-2 effector protein genes (tleA, tliA, tleB, tliB) and hrcU gene deletion, that is, the double knockout strain PXO99A with T6SS-2 effector protein deletion and T3SS inactivation constructed in the present application (T3SS / TleA-B) .

[0104] Primers for amplifying the upstream fragment of gene tliA:

[0105] PXO_02031-32-KO1:

[0106] GATTACGAATTCGAGCTCGGTGCAGACGCGCTTGCCGT (SEQ ID NO.9);

[0107] PXO_02031-34-KO2:

[0108] TCCTCGGCAAGATCGCGTCACGCATCCTGC (SEQ ID NO. 10);

[0109] Amplify the downstream primers of tleB gene:

[0110] PXO_02031-34-KO3:

[0111] TGACGCGATCTTGCCGAGGATGTGAGGGGAAG (SEQ ID NO. 11);

[0112] PXO_02033-34-KO4:

[0113] AGTCACGACGTTGTAAAACGACGGTGAGCCTGCAGGCACAT (SEQ ID NO. 12).

[0114] 2.4 Construction of ΔtleA engineered bacteria

[0115] Taking PXO99A as the starting strain, the upstream fragment of the gene tliA of about 500bp and the downstream fragment of the gene tleA of about 500bp were amplified respectively, and the upstream and downstream fragments were connected to the vector pK18mobSacB using Gibson recombination technology. After accurate sequencing, they were introduced into the PXO99A bacteria by conjugation transfer, and then SacB was used for counter-selection using sucrose to obtain the T6SS-2 effector protein and immune protein (tleA, tliA) gene deletion strains, that is, the T6SS-2 effector protein knockout strain ΔtleA constructed in the present application.

[0116] Primers for amplifying the upstream fragment of gene tliA:

[0117] PXO_02031-32-KO1: GATTACGAATTCGAGCTCGGTGCAGACGCGCTTGCCGT (SEQ ID NO.9);

[0118] PXO_02031-32-KO2:

[0119] TATGCACGCAGATCGCGTCACGCATCCTGC (SEQ ID NO. 13);

[0120] Amplify the downstream primers of tleA gene:

[0121] PXO_02031-32-KO3:

[0122] TGACGCGATCTGCGTGCATAGGGAGGGACATG (SEQ ID NO. 14);

[0123] PXO_02031-32-KO4:

[0124] AGTCACGACGTTGTAAAACGATCCGACACCAGACGCATAGACCTT (SEQ ID NO. 15).

[0125] 2.5 Construction of ΔtleB engineered bacteria

[0126] Taking PXO99A as the starting strain, the upstream fragment of the gene tliB was amplified by about 500bp, and the downstream fragment of the gene tleB was amplified by about 500bp, and the upstream and downstream fragments were connected to the vector pK18mobSacB using Gibson recombination technology. After accurate sequencing, they were introduced into the PXO99A bacteria by conjugation transfer, and then SacB was used for counter-selection using sucrose to obtain the T6SS-2 effector protein and immune protein (tleB, tliB) gene deletion strains, that is, the T6SS-2 effector protein knockout strain ΔtleB constructed in the present application.

[0127] Primers for amplifying the upstream fragment of gene tliB:

[0128] PXO_02033-34-KO1: GATTACGAATTCGAGCTCGGGATGCTGCGGCAGATCAGCAT(SEQ IDNO.16);

[0129] PXO_02033-34-KO2:

[0130] TCCTCGGCAATTTCAATGCTGGCATCACGGTCT (SEQ ID NO. 17);

[0131] Amplify the downstream primers of tleB gene:

[0132] PXO_02033-34-KO3:

[0133] AGCATTGAAATTGCCGAGGATGTGAGGGGAAG (SEQ ID NO. 18);

[0134] PXO_02033-34-KO4: AGTCACGACGTTGTAAAACGACGGTGAGCCTGCAGGCACAT (SEQ ID NO. 12).

[0135] 2.6 Construction of ΔtleA-B engineered bacteria

[0136] Taking PXO99A as the starting strain, the upstream fragment of the gene tliA of about 500bp and the downstream fragment of the gene tleB of about 500bp were amplified respectively, and the upstream and downstream fragments were connected to the vector pK18mobSacB using Gibson recombination technology. After accurate sequencing, they were introduced into the PXO99A bacteria by conjugation transfer, and then SacB was used for counter-selection using sucrose to obtain the T6SS-2 effector protein and immune protein (tleA, tliA, tleB, tliB) gene deletion strains, that is, the T6SS-2 effector protein knockout strain ΔtleA-B constructed in the present application.

[0137] The primers for amplifying the upstream fragment of the gene tliA and the primers for amplifying the downstream fragment of the gene tleB are as described above.

[0138] The construction methods of other engineered bacteria involved in the following examples refer to the above method.

[0139] Example 2

[0140] This example is a determination of the T6SS-2 secretion and bactericidal abilities of wild-type Xanthomonas oryzae (WT), a T6SS-1 inactivated strain (ΔtssB1), a T6SS-2 inactivated strain (ΔtssB2), and a strain in which both T6SS-1 and T6SS-2 were inactivated (ΔtssB1ΔtssB2).

[0141] 3.1 Secretion capacity assay

[0142] The overnight cultured Xanthomonas oryzae was added to fresh NB liquid medium at a ratio of 2.5:100 and grown to a bacterial OD of 1. The bacterial samples and secretion samples of the wild-type strain WT, T6SS-1 inactivated strain ΔtssB1, T6SS-2 inactivated strain ΔtssB2, T6SS-1 and T6SS-2 inactivated strains ΔtssB1ΔtssB2 of Xanthomonas oryzae were collected, and the T6SS-2 secretion marker protein Hcp was detected by western blotting.

[0143] Secretion sample collection process: when the bacteria grow to an OD of 1 in the liquid culture medium, take 5OD respectively and resuspend them in 2mL liquid NB culture medium; after standing at 28℃ for 1 hour, centrifuge the bacterial suspension at 10000g and room temperature for 5min twice, aspirate 1.6mL of the supernatant and place it in a new 2.0mL centrifuge tube; add 400μL of pre-cooled TCA (trichloroacetic acid) and place it at -20℃ for 30min; centrifuge the TCA precipitated sample at 15000g and 4℃ for 30 minutes, and discard the supernatant; add 300μL of acetone, centrifuge at 15000g at room temperature for 5min, discard the supernatant, and dry; add 80μL of 2× protein loading buffer and mix well, boil in a 98℃ metal bath for 10min, and centrifuge at 12000rpm for 1min; place on ice for later use.

[0144] The results are as follows Figure 2 It was shown that the lack of tssB2 could not secrete T6SS-2Hcp of Xanthomonas oryzae, while the lack of tssB1 had no effect on the secretion of T6SS-2Hcp of Xanthomonas oryzae.

[0145] 3.2 Determination of bactericidal ability

[0146] Strain culture method: Use NB liquid culture medium (containing 0.3% beef extract, 0.1% yeast powder, 0.5% polypeptone and 0.5% sucrose, unit: w / v), add corresponding antibiotics, shake at 28°C and 200 rpm, and culture overnight.

[0147] The wild-type strain WT, T6SS-1 inactivated strain ΔtssB, T6SS-2 inactivated strain (ΔtssB2), T6SS-1 and T6SS-2 inactivated strain ΔtssB1ΔtssB2 (ΔtssB1B2) cultured overnight were mixed with non-pathogenic bacteria (Escherichia coli MG1655) at an OD ratio of 10:1, and 10 μL was placed on NB plates. After incubation at 28°C for 3 h (R. solanacearum GMI1000 for 6 h), the mixed colonies were resuspended in 500 μL NB, serially diluted 10 times on corresponding resistance plates and counted.

[0148] The results are as follows Figure 3 The results showed that Xanthomonas oryzae T6SS-2 had bactericidal activity, while T6SS-1 had no bactericidal activity.

[0149] Example 3

[0150] This example is the determination of the hypersensitive response (Hypersensitive Response HR) induced by different mutants of Xanthomonas oryzae.

[0151] Xanthomonas oryzae was grown in a shaking incubator at 28°C until OD was 1. An appropriate amount of bacterial solution was centrifuged and the supernatant was discarded. The bacterial cells were resuspended in 10mM MgCl2 solution to an OD of 0.8. A 1mL needleless syringe was used to inject the bacteria into the back of 4-week-old tobacco (Nicotiana benthamiana) and the injected bacterial area was marked. 10mM MgCl2 solution was used as a negative control. The changes in leaf HR response were observed every day, and photos were taken at appropriate time points.

[0152] The results are as follows Figure 4 It was shown that the hrcU gene deletion strain could not induce tobacco hypersensitivity reaction.

[0153] Example 4

[0154] This example is a determination of the effect of Xanthomonas oryzae T6SS effector protein on the developmental ability of Arabidopsis thaliana ovules.

[0155] Add 50 μL of bacterial solution to a 200 μL PCR tube, invert it on a rod, and infect wild-type Arabidopsis Col-0 inflorescence. Xanthomonas oryzae was grown in a shaker at 28°C to an OD of 1. An appropriate amount of bacterial solution was centrifuged and the supernatant was discarded. The bacteria were resuspended in 10 mM MgCl2 solution to an OD of 0.8, and then TritonTM X-100 (Sigma T9284) was added to 1 / 1000. Before infection, the inflorescence was trimmed and only the buds were retained. Then the top of the Arabidopsis inflorescence was immersed in the bacterial solution for 3 hours. After the incubation, the PCR tube containing the solution was removed and the plants were cultured under normal environmental conditions (20-22°C, 16 hours of light, 8 hours of darkness). After 7-10 days of culture, the total number of seeds in mature siliques was counted for further analysis.

[0156] The results are as follows Figure 5 The experimental results showed that the effector proteins TleA and TleB affect ovule development.

[0157] Example 5

[0158] This example is a wild-type strain, a T6SS-2 inactivated strain, a T3SS inactivated strain, a T3SS inactivated strain lacking effector protein and immune protein PXO99A (T3SS / TleA-B) Determination of bactericidal ability of strains.

[0159] The wild-type strain, T6SS-2 inactivated strain, T3SS inactivated strain, T3SS inactivated strain lacking effector protein and immune protein PXO99A were cultured overnight. (T3SS / TleA-B) The strain was mixed with different animal pathogens (E. coli DAEC 2787, E. coli ETEC H-10407, Vibrio cholerae C6706, Citrobacter rodentium) or plant pathogens (Pseudomonas syringae pv. syringae, P. syringae pv. tomato, Ralstonia solanacearum GMI1000) at an OD ratio of 10:1. 10 μL was taken on NB plates and cultured at 28°C for 3 h (R. solanacearum GMI1000 for 6 h). Then the mixed colonies were resuspended in 500 μL NB, serially diluted 10 times on corresponding resistance plates and counted.

[0160] The results are as follows Figure 6-7 As shown. Figure 6 Showing the wild-type strain and the engineered strain PXO99A constructed by the present invention (T3SS / TleA-B) It has strong bactericidal activity against all four animal pathogenic bacteria; Figure 7Showing the wild-type strain and the engineered strain PXO99A constructed by the present invention (T3SS / TleA-B) It has strong fungicidal activity against all three plant pathogens.

[0161] The nucleic acid sequences of the main genes are as follows:

[0162] TliA (SEQ ID NO.19):

[0163] ;

[0164] TleA (SEQ ID NO.20):

[0165] ATGATGAGCGCGGGGCTGGGCCGTCCTCAGGACAGTTGCTGCATCGACTTGCGCTGGGGGTTCTTCTTCGACGGAACCAACAACAATTTTCAGAGAGACCAGCCGAAGAAGGCGCATAGCAATGTCGCCCGGCTCTACGACATTTTCGAGGCCGACCGAAGAAAGCCAGAATTCGTAAGGCGCTACGCCGCAGGCGTGGGCACCGCGTTCAAGGACGAAGTGGGCGATCAGGGATTGGGGATCCAGGAAAAAGCCGGCCTGGCCGCAGGCTGGGGCGGCGAGGCGCGGATCTGCTGGGCGTTGCTCAAGTTCCTGGATAATCTCAATTATTACTTCGAACGGATCGACCTTGGTGAAGCGCTAGGCCAGAAGGACCCAGGCACCGTGCGGCGCATGGCCCAGGACATGACGATTCCGTCGATGGAACTGCGCAAGATCGCCGGCGACGAAACCGAGATGCTGCGGCAGATCAGCATGATGGCCTCGCTCCAGAGCCTGACCGCCACGGCCTTGAATCCGCCGAATCACCGCGGCCGCCGCGCCGTGCTGGCCGAGCGCCGCGCGCAGCTGCGGCAACGCGTGCAGACATGGCAGCGCGCGCAGCCCAAGCCGAAGCTGCGCAGCATCCGTGTCTCGGTGTTCGGCTTCTCGCGCGGCGCGGCCGAGGCCCGGGTGTTCTGCAGCTGGCTCAAGGATGCCTGCGATGGCGGCGGGGGCGAGCTGACGCTGTGCGGCATCCCGGTGCAGCTGGACCTGCTGGGCATCTTCGATACGGTGGCGTCGGTGGGCCTGGCGAACAGCTCGCGCCTGTGGAGCGGCCATGGCGGCTACGCAAGCGAGGACGACCTGCGGATCGCCCCTGATGTGCGCCGCTGCGTGCATAGGGAGGGACATGACTGA;

[0166] TliB(SEQ ID NO.21):

[0167] ;

[0168] TleB(SEQ ID NO.22):

[0169]

[0170] hrcU(SEQ ID NO.23):

[0171]

[0172] The technical features of the above-described embodiments may be arbitrarily combined. To make the description concise, not all possible combinations of the technical features in the above-described embodiments are described. However, as long as there is no contradiction in the combination of these technical features, they should be considered to be within the scope of this specification.

[0173] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the patent of the present application shall be subject to the attached claims, and the description may be used to interpret the content of the claims.

Claims

1. An engineered bacterium of Xanthomonas oryzae, characterized in that: Compared with the wild-type Xanthomonas oryzae, the engineered bacteria meets one or more of the following conditions: (1) T3SS inactivation; (2) The tleA gene and the tliA gene are deleted; or / and, the tleB gene and the tliB gene are deleted.

2. The engineered bacteria according to claim 1, characterized in that In the engineered bacteria, T3SS is inactivated, and tleA gene, tliA gene, tleB gene and tliB gene are deleted.

3. The engineered bacteria according to claim 1, characterized in that The wild-type Xanthomonas oryzae includes the PXO99A strain.

4. The engineered bacteria according to claim 1, characterized in that The hrcU gene is deleted in the engineered bacteria.

5. The method for constructing an engineered bacterium according to any one of claims 1 to 4, characterized in that: The construction method comprises the following steps: The wild-type Xanthomonas oryzae is used as the starting bacterium, and the starting bacterium is obtained by one or more of the following methods: (1) Inactivation of T3SS; (2) knocking out the tleA gene and the tliA gene; or / and, knocking out the tleB gene and the tliB gene.

6. The construction method according to claim 5, characterized in that: The step of inactivating the T3SS includes knocking out the hrcU gene.

7. The construction method according to claim 5 or 6, characterized in that: Knockout methods include homologous recombination exchange.

8. The construction method according to claim 7, characterized in that: The steps to knock out the hrcU gene include: Connecting the upstream gene fragment and the downstream gene fragment of the hrcU gene to the suicide vector to obtain a recombinant suicide plasmid vector; The recombinant suicide plasmid vector is introduced into the starting bacteria to screen the hrcU gene knockout strain.

9. The construction method according to claim 7, characterized in that: Knocking out the tleA gene, the tliA gene, the tleB gene and the tliB gene comprises the following steps: The upstream gene fragment of the tliA gene and the downstream gene fragment of the tleB gene are connected to the suicide vector to obtain a recombinant suicide plasmid vector; The recombinant suicide plasmid vector is introduced into the starting bacteria or the hrcU gene knockout strain, and the tleA, tliA, tleB and tleB gene knockout strains are screened.

10. Use of the engineered bacteria according to any one of claims 1 to 4 in: (1) Preparation of products for the prevention and treatment of animal and plant pathogens; (2) Preparation of pesticides for preventing and controlling plant diseases.

11. The use according to claim 10, characterized in that The animal pathogenic bacteria include one or more of E. coli DAEC2787, E. coli ETEC H-10407, Vibrio cholerae C6706 and Citrobacter rodentium; The plant pathogenic bacteria include one or more of Pseudomonas syringae pv.syringae, P.syringae pv.tomato, and Ralstonia solanacearum GMI1000.

12. A product, characterized in that The product comprises the engineered bacteria according to any one of claims 1 to 4.